Lymphatic Osteopathic Manipulative Medicine to Enhance Coronavirus (COVID-19) Vaccination Efficacy

Rowan University

Status: Withdrawn

Conditions: COVID-19

Treatments: Other: Lymphatic OMM; Other: Light Touch

Study type: Interventional

Funder types: Other

Identifiers

NCT05069636

PRO-2021-519

Details and patient eligibility

About

The purpose of this project is to study the impact of Osteopathic Manipulative Medicine (OMM) treatments, such as lymphatic myofascial release and thoracic pump techniques severe acute respiratory syndrome-associated coronavirus 2 (SARS-Cov-2) antibody levels in patients who receive the mRNA-1273 (Moderna) COVID-19 vaccine and to consider if these OMM strategies allow a stronger more robust immune response.

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Inclusion criteria will include age greater than 18 years old and having safely received the COVID-19 vaccine.

Exclusion criteria

• Exclusion criteria will include age under 18 years old, malignancy/cancer, ongoing infection, coagulopathy history, use of anticoagulant medications, and fracture or acute injury of the torso neck or upper extremities. Lymphatic OMM is safe during pregnancy and this does not need to be an exclusion criteria.

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

0 participants in 2 patient groups

Lymphatic OMM plus Moderna COVID-19 Vaccine regimen

Experimental group

Description:

Patients receive OMM treatments that will include thoracic inlet and outlet myofascial release, pectoral traction myofascial release, and Miller Thoracic Lymphatic Pump technique plus the Moderna COVID-19 Vaccine regimen.

Treatment:

Other: Lymphatic OMM

Light Touch plus Moderna COVID-19 Vaccine regimen

Sham Comparator group

Description:

Patients receive a series of light touch techniques plus the Moderna COVID-19 Vaccine regimen.

Treatment:

Other: Light Touch